These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 25405724)

  • 21. Protective Efficacy of Plasmodium vivax Radiation-Attenuated Sporozoites in Colombian Volunteers: A Randomized Controlled Trial.
    Arévalo-Herrera M; Vásquez-Jiménez JM; Lopez-Perez M; Vallejo AF; Amado-Garavito AB; Céspedes N; Castellanos A; Molina K; Trejos J; Oñate J; Epstein JE; Richie TL; Herrera S
    PLoS Negl Trop Dis; 2016 Oct; 10(10):e0005070. PubMed ID: 27760143
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reproducibility of malaria sporozoite challenge model in humans for evaluating efficacy of vaccines and drugs: a systematic review.
    Shibeshi W; Bagchus W; Yalkinoglu Ö; Tappert A; Engidawork E; Oeuvray C
    BMC Infect Dis; 2021 Dec; 21(1):1274. PubMed ID: 34930178
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Safety, Immunogenicity, and Protective Efficacy against Controlled Human Malaria Infection of
    Jongo SA; Shekalaghe SA; Church LWP; Ruben AJ; Schindler T; Zenklusen I; Rutishauser T; Rothen J; Tumbo A; Mkindi C; Mpina M; Mtoro AT; Ishizuka AS; Kassim KR; Milando FA; Qassim M; Juma OA; Mwakasungula S; Simon B; James ER; Abebe Y; Kc N; Chakravarty S; Saverino E; Bakari BM; Billingsley PF; Seder RA; Daubenberger C; Sim BKL; Richie TL; Tanner M; Abdulla S; Hoffman SL
    Am J Trop Med Hyg; 2018 Aug; 99(2):338-349. PubMed ID: 29943719
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnosis and treatment based on quantitative PCR after controlled human malaria infection.
    Walk J; Schats R; Langenberg MC; Reuling IJ; Teelen K; Roestenberg M; Hermsen CC; Visser LG; Sauerwein RW
    Malar J; 2016 Aug; 15(1):398. PubMed ID: 27495296
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Attenuated PfSPZ Vaccine induces strain-transcending T cells and durable protection against heterologous controlled human malaria infection.
    Lyke KE; Ishizuka AS; Berry AA; Chakravarty S; DeZure A; Enama ME; James ER; Billingsley PF; Gunasekera A; Manoj A; Li M; Ruben AJ; Li T; Eappen AG; Stafford RE; Kc N; Murshedkar T; Mendoza FH; Gordon IJ; Zephir KL; Holman LA; Plummer SH; Hendel CS; Novik L; Costner PJ; Saunders JG; Berkowitz NM; Flynn BJ; Nason MC; Garver LS; Laurens MB; Plowe CV; Richie TL; Graham BS; Roederer M; Sim BK; Ledgerwood JE; Hoffman SL; Seder RA
    Proc Natl Acad Sci U S A; 2017 Mar; 114(10):2711-2716. PubMed ID: 28223498
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Safety and clinical outcome of experimental challenge of human volunteers with Plasmodium falciparum-infected mosquitoes: an update.
    Epstein JE; Rao S; Williams F; Freilich D; Luke T; Sedegah M; de la Vega P; Sacci J; Richie TL; Hoffman SL
    J Infect Dis; 2007 Jul; 196(1):145-54. PubMed ID: 17538895
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Optimizing Intradermal Administration of Cryopreserved Plasmodium falciparum Sporozoites in Controlled Human Malaria Infection.
    Lyke KE; Laurens MB; Strauss K; Adams M; Billingsley PF; James E; Manoj A; Chakravarty S; Plowe CV; Li ML; Ruben A; Edelman R; Green M; Dube TJ; Sim BKL; Hoffman SL
    Am J Trop Med Hyg; 2015 Dec; 93(6):1274-1284. PubMed ID: 26416102
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term protection against malaria after experimental sporozoite inoculation: an open-label follow-up study.
    Roestenberg M; Teirlinck AC; McCall MB; Teelen K; Makamdop KN; Wiersma J; Arens T; Beckers P; van Gemert G; van de Vegte-Bolmer M; van der Ven AJ; Luty AJ; Hermsen CC; Sauerwein RW
    Lancet; 2011 May; 377(9779):1770-6. PubMed ID: 21514658
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A genetically engineered
    Murphy SC; Vaughan AM; Kublin JG; Fishbauger M; Seilie AM; Cruz KP; Mankowski T; Firat M; Magee S; Betz W; Kain H; Camargo N; Haile MT; Armstrong J; Fritzen E; Hertoghs N; Kumar S; Sather DN; Pinder LF; Deye GA; Galbiati S; Geber C; Butts J; Jackson LA; Kappe SHI
    Sci Transl Med; 2022 Aug; 14(659):eabn9709. PubMed ID: 36001680
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recombinant Liver Stage Antigen-1 (LSA-1) formulated with AS01 or AS02 is safe, elicits high titer antibody and induces IFN-gamma/IL-2 CD4+ T cells but does not protect against experimental Plasmodium falciparum infection.
    Cummings JF; Spring MD; Schwenk RJ; Ockenhouse CF; Kester KE; Polhemus ME; Walsh DS; Yoon IK; Prosperi C; Juompan LY; Lanar DE; Krzych U; Hall BT; Ware LA; Stewart VA; Williams J; Dowler M; Nielsen RK; Hillier CJ; Giersing BK; Dubovsky F; Malkin E; Tucker K; Dubois MC; Cohen JD; Ballou WR; Heppner DG
    Vaccine; 2010 Jul; 28(31):5135-44. PubMed ID: 19737527
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Infectivity of
    McCall MBB; Wammes LJ; Langenberg MCC; van Gemert GJ; Walk J; Hermsen CC; Graumans W; Koelewijn R; Franetich JF; Chishimba S; Gerdsen M; Lorthiois A; van de Vegte M; Mazier D; Bijker EM; van Hellemond JJ; van Genderen PJJ; Sauerwein RW
    Sci Transl Med; 2017 Jun; 9(395):. PubMed ID: 28637923
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of human Pegivirus infections in whole Plasmodium falciparum sporozoite vaccination and controlled human malaria infection in African volunteers.
    Tumbo AM; Schindler T; Dangy JP; Orlova-Fink N; Bieri JR; Mpina M; Milando FA; Juma O; Hamad A; Nyakarungu E; Chemba M; Mtoro A; Ramadhan K; Olotu A; Makweba D; Mgaya S; Stuart K; Perreau M; Stapleton JT; Jongo S; Hoffman SL; Tanner M; Abdulla S; Daubenberger C
    Virol J; 2021 Jan; 18(1):28. PubMed ID: 33499880
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Towards an RTS,S-based, multi-stage, multi-antigen vaccine against falciparum malaria: progress at the Walter Reed Army Institute of Research.
    Heppner DG; Kester KE; Ockenhouse CF; Tornieporth N; Ofori O; Lyon JA; Stewart VA; Dubois P; Lanar DE; Krzych U; Moris P; Angov E; Cummings JF; Leach A; Hall BT; Dutta S; Schwenk R; Hillier C; Barbosa A; Ware LA; Nair L; Darko CA; Withers MR; Ogutu B; Polhemus ME; Fukuda M; Pichyangkul S; Gettyacamin M; Diggs C; Soisson L; Milman J; Dubois MC; Garçon N; Tucker K; Wittes J; Plowe CV; Thera MA; Duombo OK; Pau MG; Goudsmit J; Ballou WR; Cohen J
    Vaccine; 2005 Mar; 23(17-18):2243-50. PubMed ID: 15755604
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chemoprophylaxis Vaccination: Phase I Study to Explore Stage-specific Immunity to Plasmodium falciparum in US Adults.
    Healy SA; Murphy SC; Hume JCC; Shelton L; Kuntz S; Van Voorhis WC; Moodie Z; Metch B; Wang R; Silver-Brace T; Fishbaugher M; Kennedy M; Finney OC; Chaturvedi R; Marcsisin SR; Hobbs CV; Warner-Lubin M; Talley AK; Wong-Madden S; Stuart K; Wald A; Kappe SH; Kublin JG; Duffy PE
    Clin Infect Dis; 2020 Sep; 71(6):1481-1490. PubMed ID: 31621832
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Protection against
    Epstein JE; Paolino KM; Richie TL; Sedegah M; Singer A; Ruben AJ; Chakravarty S; Stafford A; Ruck RC; Eappen AG; Li T; Billingsley PF; Manoj A; Silva JC; Moser K; Nielsen R; Tosh D; Cicatelli S; Ganeshan H; Case J; Padilla D; Davidson S; Garver L; Saverino E; Murshedkar T; Gunasekera A; Twomey PS; Reyes S; Moon JE; James ER; Kc N; Li M; Abot E; Belmonte A; Hauns K; Belmonte M; Huang J; Vasquez C; Remich S; Carrington M; Abebe Y; Tillman A; Hickey B; Regules J; Villasante E; Sim BKL; Hoffman SL
    JCI Insight; 2017 Jan; 2(1):e89154. PubMed ID: 28097230
    [No Abstract]   [Full Text] [Related]  

  • 36. Modest heterologous protection after Plasmodium falciparum sporozoite immunization: a double-blind randomized controlled clinical trial.
    Walk J; Reuling IJ; Behet MC; Meerstein-Kessel L; Graumans W; van Gemert GJ; Siebelink-Stoter R; van de Vegte-Bolmer M; Janssen T; Teelen K; de Wilt JHW; de Mast Q; van der Ven AJ; Diez Benavente E; Campino S; Clark TG; Huynen MA; Hermsen CC; Bijker EM; Scholzen A; Sauerwein RW
    BMC Med; 2017 Sep; 15(1):168. PubMed ID: 28903777
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Randomized Trial Evaluating the Prophylactic Activity of DSM265 Against Preerythrocytic Plasmodium falciparum Infection During Controlled Human Malarial Infection by Mosquito Bites and Direct Venous Inoculation.
    Murphy SC; Duke ER; Shipman KJ; Jensen RL; Fong Y; Ferguson S; Janes HE; Gillespie K; Seilie AM; Hanron AE; Rinn L; Fishbaugher M; VonGoedert T; Fritzen E; Kappe SH; Chang M; Sousa JC; Marcsisin SR; Chalon S; Duparc S; Kerr N; Möhrle JJ; Andenmatten N; Rueckle T; Kublin JG
    J Infect Dis; 2018 Feb; 217(5):693-702. PubMed ID: 29216395
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of malaria preexposure on antiparasite cellular and humoral immune responses after controlled human malaria infection.
    Obiero JM; Shekalaghe S; Hermsen CC; Mpina M; Bijker EM; Roestenberg M; Teelen K; Billingsley PF; Sim BK; James ER; Daubenberger CA; Hoffman SL; Abdulla S; Sauerwein RW; Scholzen A
    Infect Immun; 2015 May; 83(5):2185-96. PubMed ID: 25776749
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Susceptibility of Panamanian Aotus lemurinus lemurinus to sporozoite-induced Plasmodium falciparum (Santa Lucia) infection.
    Gramzinski RA; Obaldia N; Jones TR; Rossan RN; Collins WE; Garrett DO; Lal AA; Hoffman SL
    Am J Trop Med Hyg; 1999 Jul; 61(1):19-25. PubMed ID: 10432049
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development of cultured Plasmodium falciparum blood-stage malaria cell banks for early phase in vivo clinical trial assessment of anti-malaria drugs and vaccines.
    Stanisic DI; Liu XQ; De SL; Batzloff MR; Forbes T; Davis CB; Sekuloski S; Chavchich M; Chung W; Trenholme K; McCarthy JS; Li T; Sim BK; Hoffman SL; Good MF
    Malar J; 2015 Apr; 14():143. PubMed ID: 25890156
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.